Medtronic has received CE mark for its Percept RC neurostimulator for deep brain stimulation (DBS). The smallest and thinnest device on the market, Percept RC is the a rechargeable DBS system with BrainSense sensing technology.
Omini, a medtech company developing the first multiplexed blood testing platform for personalised medicine and chronic disease management, has been given approval by European authorities of a patent for its multi-gate Organic Electro-Chemical Transistor (OECT)-based detection device comprising depolarisation electrode.
The clearance positions BD and partner Babson Diagnostics to support blood collection from community sites such as pharmacies.
CAMH-led pre-clinical studies using a small molecule drug have shown promise as a potential new treatment for multiple sclerosis (MS). The results have been published in the journal Science Advances.
Researchers at Case Western Reserve University and University Hospitals have identified an enzyme that blocks insulin produced in the body—a discovery that could provide a new target to treat diabetes.
Easee, a digital healthcare speicalist, has achieved the CE mark Class II under the new European Union Medical Device Regulation (Regulation (EU) 2017/745) (EU-MDR) which the company says is the world’s first and only CE certified online eye exam with refraction capabilities.
Bioliberty, a medtech start-up which has created a soft robotic glove to help rehabilitate stroke patients, has received almost half a million pounds of new funding to accelerate its product to market.
SiteRite™ 9 Ultrasound System Delivers Enhanced Image Quality and Vessel Assessment Tools to Aid in First Attempt IV Insertion Success
The XO Cath microcatheter is designed to deliver new levels of trackability, torque response, and embolic compatibility for improved treatment delivery.
The clearance positions the company to offer an alternative to continuous positive airway pressure devices and neurostimulation implants.